Blue Fin Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.2M | Sell |
26,625
-2,090
| -7% | -$241K | 0.53% | 42 |
|
|
2025
Q4 | $3.02M | Sell |
28,715
-636
| -2% | -$59.7K | 0.47% | 41 |
|
|
2025
Q3 | $2.46M | Sell |
29,351
-586
| -2% | -$48.3K | 0.39% | 47 |
|
|
2025
Q2 | $2.37M | Sell |
29,937
-530
| -2% | -$42.1K | 0.4% | 48 |
|
|
2025
Q1 | $2.73M | Sell |
30,467
-282
| -0.9% | -$26.3K | 0.53% | 38 |
|
|
2024
Q4 | $3.06M | Sell |
30,749
-1
| -0% | -$103 | 0.56% | 35 |
|
|
2024
Q3 | $3.49M | Sell |
30,750
-51
| -0.2% | -$6.06K | 0.66% | 33 |
|
|
2024
Q2 | $3.81M | Buy |
30,801
+68
| +0.2% | +$8.76K | 0.76% | 24 |
|
|
2024
Q1 | $4.06M | Sell |
30,733
-555
| -2% | -$68.4K | 0.9% | 23 |
|
|
2023
Q4 | $3.41M | Sell |
31,288
-167
| -0.5% | -$17.3K | 0.88% | 24 |
|
|
2023
Q3 | $3.24M | Buy |
31,455
+170
| +0.5% | +$18.3K | 0.95% | 22 |
|
|
2023
Q2 | $3.61M | Buy |
31,285
+2
| +0% | +$227 | 1.03% | 21 |
|
|
2023
Q1 | $3.67M | Buy |
31,283
+87
| +0.3% | +$9.39K | 1.19% | 20 |
|
|
2022
Q4 | $3.46M | Buy |
31,196
+73
| +0.2% | +$7.46K | 1.27% | 22 |
|
|
2022
Q3 | $2.68M | Buy |
31,123
+1,242
| +4% | +$111K | 1.01% | 27 |
|
|
2022
Q2 | $2.72M | Buy |
29,881
+37
| +0.1% | +$3.28K | 0.96% | 28 |
|
|
2022
Q1 | $2.45M | Buy |
29,844
+141
| +0.5% | +$11.1K | 0.71% | 36 |
|
|
2021
Q4 | $2.28M | Sell |
29,703
-459
| -2% | -$36.6K | 0.63% | 41 |
|
|
2021
Q3 | $2.27M | Sell |
30,162
-177
| -0.6% | -$13.5K | 0.69% | 37 |
|
|
2021
Q2 | $2.36M | Sell |
30,339
-1,415
| -4% | -$105K | 0.73% | 35 |
|
|
2021
Q1 | $2.33M | Buy |
31,754
+134
| +0.4% | +$9.88K | 0.8% | 35 |
|
|
2020
Q4 | $2.47M | Buy |
31,620
+670
| +2% | +$51.2K | 0.88% | 29 |
|
|
2020
Q3 | $2.45M | Buy |
30,950
+230
| +0.7% | +$18K | 0.99% | 26 |
|
|
2020
Q2 | $2.27M | Buy |
30,720
+493
| +2% | +$37.1K | 1% | 27 |
|
|
2020
Q1 | $2.22M | Sell |
30,227
-313
| -1% | -$24.6K | 1.22% | 20 |
|
|
2019
Q4 | $2.65M | Buy |
30,540
+838
| +3% | +$68.8K | 1.25% | 20 |
|
|
2019
Q3 | $2.38M | Sell |
29,702
-1,813
| -6% | -$145K | 1.25% | 21 |
|
|
2019
Q2 | $2.52M | Buy |
31,515
+186
| +0.6% | +$14.2K | 1.3% | 17 |
|
|
2019
Q1 | $2.49M | Sell |
31,329
-491
| -2% | -$36.7K | 1.31% | 18 |
|
|
2018
Q4 | $2.32M | Buy |
31,820
+139
| +0.4% | +$9.81K | 1.39% | 17 |
|
|
2018
Q3 | $2.15M | Sell |
31,681
-194
| -0.6% | -$12.4K | 1.06% | 25 |
|
|
2018
Q2 | $1.85M | Buy |
31,875
+1,422
| +5% | +$80.2K | 0.99% | 26 |
|
|
2018
Q1 | $1.58M | Buy |
30,453
+3,003
| +11% | +$162K | 0.89% | 30 |
|
|
2017
Q4 | $1.47M | Sell |
27,450
-2,107
| -7% | -$117K | 0.86% | 33 |
|
|
2017
Q3 | $1.8M | Buy |
29,557
+95
| +0.3% | +$5.76K | 1.11% | 23 |
|
|
2017
Q2 | $1.8M | Sell |
29,462
-184
| -0.6% | -$11.2K | 1.16% | 22 |
|
|
2017
Q1 | $1.8M | Buy |
29,646
+2,484
| +9% | +$151K | 1.1% | 26 |
|
|
2016
Q4 | $1.53M | Buy |
27,162
+5,691
| +27% | +$333K | 1.01% | 32 |
|
|
2016
Q3 | $1.28M | Sell |
21,471
-771
| -3% | -$45.1K | 1.04% | 29 |
|
|
2016
Q2 | $1.22M | Sell |
22,242
-288
| -1% | -$15.3K | 1.01% | 31 |
|
|
2016
Q1 | $1.14M | Sell |
22,530
-3,794
| -14% | -$186K | 0.97% | 31 |
|
|
2015
Q4 | $1.33M | Buy |
26,324
+545
| +2% | +$27.5K | 1.02% | 27 |
|
|
2015
Q3 | $1.22M | Buy |
25,779
+367
| +1% | +$19.5K | 0.95% | 31 |
|
|
2015
Q2 | $1.38M | Buy |
25,412
+576
| +2% | +$32.3K | 0.99% | 26 |
|
|
2015
Q1 | $1.36M | Buy |
24,836
+105
| +0.4% | +$5.95K | 0.98% | 26 |
|
|
2014
Q4 | $1.34M | Buy |
24,731
+608
| +3% | +$33.9K | 1.01% | 29 |
|
|
2014
Q3 | $1.36M | Buy |
24,123
+315
| +1% | +$17.7K | 1.08% | 24 |
|
|
2014
Q2 | $1.31M | Buy |
23,808
+995
| +4% | +$54.3K | 1.05% | 25 |
|
|
2014
Q1 | $1.24M | Buy |
22,813
+58
| +0.3% | +$3K | 1.09% | 25 |
|
|
2013
Q4 | $1.09M | Buy |
+22,755
| New | +$1.04M | 0.97% | 32 |
|
Other funds holding MRK
VCM
VPM
Blue Fin Capital's MRK Position: Q1 2026 in Review
Blue Fin Capital reduced its Merck (MRK) stake by 7.3% in Q1 2026, selling an estimated $241K and leaving 26,625 shares worth $3.2M. The position accounts for 0.53% of the portfolio, ranked #42.
Blue Fin Capital first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.06M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Blue Fin Capital held 26,625 shares of Merck worth $3.2M as of Q1 2026.
- Blue Fin Capital sold 2,090 Merck shares in Q1 2026, an estimated $241K.
- Merck made up 0.53% of Blue Fin Capital's portfolio in Q1 2026, its #42 holding.
- Blue Fin Capital first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
- Blue Fin Capital's Merck position peaked at $4.06M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Blue Fin Capital's 13F filing for Q1 2026, filed 28 May 2026.